Gallium Ga 68-labeled PSMA-11 PET/MR in Diagnosing Patients with Recurrent Prostate Cancer

Inclusion Criteria

• Biopsy proven adenocarcinoma of the prostate
• Initially treated with definitive local therapy (surgery and radiation therapy are the most common treatments, but other treatments are also eligible)
• For patients initially treated with surgery, radiation therapy, brachytherapy, or cryotherapy: * PSA >= 0.2 ng/mL in at least two consecutive tests within 6 months of date of consent for patients ** Note: The most recent PSA value must be within 6 weeks of consent
• For patients who have received additional treatment in the recurrent or metastatic setting: * PSA >= 0.2 ng/ml above the most recent therapy nadir
• Age >= 18 years
• Patient must be able to tolerate PET/CT or PET/MR imaging

Exclusion Criteria

• Patient with claustrophobia that would preclude PET/CT or PET/MR imaging or other contraindications to CT imaging